{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:52:12Z","timestamp":1770227532200,"version":"3.49.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001338"],"award-info":[{"award-number":["82001338"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2021JJ40934"],"award-info":[{"award-number":["2021JJ40934"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","award":["2020JJ4854"],"award-info":[{"award-number":["2020JJ4854"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Changsha Municipal Natural Science Foundation","award":["kq2014260"],"award-info":[{"award-number":["kq2014260"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome (MetS), and the relationship between NAFLD and metabolic deterioration remains unclear. This study aimed to investigate dynamic changes in metabolically healthy phenotypes and to assess the impact of non-alcoholic fatty liver disease (NAFLD) on the conversion from metabolically healthy (MH) to metabolically unhealthy (MU) phenotypes across body shape phenotypes and phenotypic change patterns. We defined body shape phenotypes using both the body mass index (BMI) and waist circumference (WC) and defined metabolic health as individuals scoring\u2009\u2264\u20091 on the NCEP-ATP III criteria, excluding WC. A total of 12,910 Chinese participants who were MH at baseline were enrolled in 2013 and followed-up in 2019 or 2020. During a median follow-up of 6.9\u00a0years, 27.0% (n\u2009=\u20093,486) of the MH individuals developed an MU phenotype. According to the multivariate Cox analyses, NAFLD was a significant predictor of conversion from the MH to MU phenotype, independent of potential confounders (HR: 1.12; 95% confidence interval: 1.02\u20131.22). For the MH-normal weight group, the relative risk of NAFLD in phenotypic conversion was 1.21 (95% CI 1.03\u20131.41, <jats:italic>P<\/jats:italic>\u2009=\u20090.017), which was relatively higher than that of MH-overweight\/obesity group (HR: 1.14, 95% CI 1.02\u20131.26, <jats:italic>P<\/jats:italic>\u2009=\u20090.013). Interestingly, the effect of NAFLD at baseline on MH deterioration was stronger in the \u201clean\u201d phenotype group than in the \u201cnon-lean\u201d phenotype group at baseline and in the \u201cfluctuating non-lean\u201d phenotype change pattern group than in the \u201cstable non-lean\u201d phenotype change pattern group during follow-up. In conclusion, lean NAFLD is not as benign as currently considered and requires more attention during metabolic status screening.<\/jats:p>","DOI":"10.1038\/s41598-022-18988-x","type":"journal-article","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T22:11:53Z","timestamp":1661897513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Association between non-alcoholic fatty liver disease and metabolically healthy deterioration across different body shape phenotypes at baseline and change patterns"],"prefix":"10.1038","volume":"12","author":[{"given":"Liu","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Changfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Jiangang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Zhiheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Xiaoling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deng","family":"Yuling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Yaqin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"18988_CR1","unstructured":"The State Council Information Office of the People\u2019s Republic of China. Press briefing for the Report on Chinese Residents\u2019 Chronic Diseases and Nutrition 2020. December 24, 2020 (in Chinese). http:\/\/www.gov.cn\/xinwen\/2020-12\/24\/content_5572983.htm (accessed Dec 26, 2020)."},{"issue":"6","key":"18988_CR2","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","volume":"9","author":"XF Pan","year":"2021","unstructured":"Pan, X. F., Wang, L. & Pan, A. Epidemiology and determinants of obesity in China. Lancet Diabetes Endocrinol. 9(6), 373\u2013392 (2021).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"18988_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000506689","volume":"13","author":"M Momin","year":"2020","unstructured":"Momin, M. et al. Joint effects of body mass index and waist circumference on the incidence of hypertension in a community-based Chinese population. Obes. Facts 13(2), 245\u2013255 (2020).","journal-title":"Obes. Facts"},{"issue":"6","key":"18988_CR4","doi-asserted-by":"publisher","first-page":"e630","DOI":"10.1016\/S2214-109X(18)30216-X","volume":"6","author":"Z Chen","year":"2018","unstructured":"Chen, Z. et al. Adiposity and risk of ischaemic and haemorrhagic stroke in 0\u00b75 million Chinese men and women: A prospective cohort study. Lancet Glob Health 6(6), e630\u2013e640 (2018).","journal-title":"Lancet Glob Health"},{"issue":"2","key":"18988_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","volume":"1","author":"N Stefan","year":"2013","unstructured":"Stefan, N. et al. Metabolically healthy obesity: Epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 1(2), 152\u2013162 (2013).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"18988_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S2213-8587(17)30292-9","volume":"6","author":"N Stefan","year":"2018","unstructured":"Stefan, N., H\u00e4ring, H. U. & Schulze, M. B. Metabolically healthy obesity: The low-hanging fruit in obesity treatment? Lancet Diabetes Endocrinol. 6(3), 249\u2013258 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"9","key":"18988_CR7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1177\/2047487315623884","volume":"23","author":"N Eckel","year":"2016","unstructured":"Eckel, N. et al. Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 23(9), 956\u2013966 (2016).","journal-title":"Eur. J. Prev. Cardiol."},{"key":"18988_CR8","doi-asserted-by":"crossref","unstructured":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 363 (9403), 157\u2013163 (2004).","DOI":"10.1016\/S0140-6736(03)15268-3"},{"issue":"1","key":"18988_CR9","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1136\/bmjdrc-2019-000879","volume":"8","author":"B Mi","year":"2020","unstructured":"Mi, B. et al. Long-term BMI change trajectories in Chinese adults and its association with the hazard of type 2 diabetes: Evidence from a 20-year China Health and Nutrition Survey. BMJ Open Diabetes Res. Care 8(1), 552 (2020).","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"9","key":"18988_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","volume":"7","author":"IJ Neeland","year":"2019","unstructured":"Neeland, I. J. et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: A position statement. Lancet Diabetes Endocrinol. 7(9), 715\u2013725 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"18988_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/oby.22638","volume":"28","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. Waist circumference change is associated with blood pressure change independent of BMI change. Obesity (Silver Spring) 28(1), 146\u2013153 (2020).","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"18988_CR12","first-page":"e179635","volume":"12","author":"YM Kang","year":"2017","unstructured":"Kang, Y. M. et al. Visceral adiposity index predicts the conversion of metabolically healthy obesity to an unhealthy phenotype. PLoS ONE 12(6), e179635 (2017).","journal-title":"PLoS ONE"},{"issue":"5","key":"18988_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","volume":"4","author":"J Li","year":"2019","unstructured":"Li, J. et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 4(5), 389\u2013398 (2019).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"18988_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi, Z. M. et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1), 73\u201384 (2016).","journal-title":"Hepatology"},{"issue":"6","key":"18988_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4093\/dmj.2017.41.6.430","volume":"41","author":"E Han","year":"2017","unstructured":"Han, E. & Lee, Y. H. Non-alcoholic fatty liver disease: The emerging burden in cardiometabolic and renal diseases. Diabetes Metab. J. 41(6), 430\u2013437 (2017).","journal-title":"Diabetes Metab. J."},{"issue":"13","key":"18988_CR16","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1017\/S136898002000289X","volume":"24","author":"R Xu","year":"2021","unstructured":"Xu, R. et al. BMI, high-sensitivity C-reactive protein and the conversion from metabolically healthy to unhealthy phenotype in Chinese adults: A cohort study. Public Health Nutr. 24(13), 4124\u20134131 (2021).","journal-title":"Public Health Nutr."},{"issue":"9","key":"18988_CR17","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/ijo.2015.75","volume":"39","author":"YC Hwang","year":"2015","unstructured":"Hwang, Y. C. et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. Int. J. Obes. (Lond) 39(9), 1365\u20131370 (2015).","journal-title":"Int. J. Obes. (Lond)"},{"issue":"18","key":"18988_CR18","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1161\/CIRCULATIONAHA.111.065904","volume":"125","author":"W Yang","year":"2012","unstructured":"Yang, W. et al. Serum lipids and lipoproteins in Chinese men and women. Circulation 125(18), 2212\u20132221 (2012).","journal-title":"Circulation"},{"issue":"10","key":"18988_CR19","first-page":"1366","volume":"37","author":"DH Jin","year":"2016","unstructured":"Jin, D. H. et al. Changes on patterns of sleep duration: Findings from China Health and Nutrition Survey in population in 9 provinces. Zhonghua Liu Xing Bing Xue Za Zhi 37(10), 1366\u20131369 (2016).","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"1","key":"18988_CR20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1053\/j.ackd.2017.10.005","volume":"25","author":"BW Teo","year":"2018","unstructured":"Teo, B. W. et al. Glomerular filtration rates in Asians. Adv. Chronic Kidney Dis. 25(1), 41\u201348 (2018).","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"3","key":"18988_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1046\/j.1467-789X.2002.00065.x","volume":"3","author":"P Deurenberg","year":"2002","unstructured":"Deurenberg, P., Deurenberg-Yap, M. & Guricci, S. Asians are different from Caucasians and from each other in their body mass index\/body fat per cent relationship. Obes. Rev. 3(3), 141\u2013146 (2002).","journal-title":"Obes. Rev."},{"issue":"8","key":"18988_CR22","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.2337\/dc12-1971","volume":"36","author":"SL Appleton","year":"2013","unstructured":"Appleton, S. L. et al. Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: A cohort study. Diabetes Care 36(8), 2388\u20132394 (2013).","journal-title":"Diabetes Care"},{"issue":"3","key":"18988_CR23","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/sj.ijo.0803175","volume":"30","author":"J Stevens","year":"2006","unstructured":"Stevens, J. et al. The definition of weight maintenance. Int. J. Obes. (Lond) 30(3), 391\u2013399 (2006).","journal-title":"Int. J. Obes. (Lond)"},{"issue":"1","key":"18988_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12937-016-0221-6","volume":"15","author":"H Dai","year":"2016","unstructured":"Dai, H. et al. Association between homocysteine and non-alcoholic fatty liver disease in Chinese adults: A cross-sectional study. Nutr. J. 15(1), 102 (2016).","journal-title":"Nutr. J."},{"issue":"6","key":"18988_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1440-1746.2007.05002.x","volume":"22","author":"GC Farrell","year":"2007","unstructured":"Farrell, G. C. et al. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary. J. Gastroenterol. Hepatol. 22(6), 775\u2013777 (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"8","key":"18988_CR26","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/oby.22536","volume":"27","author":"YC Hwang","year":"2019","unstructured":"Hwang, Y. C., Ahn, H. Y. & Park, C. Y. Association between nonalcoholic fatty liver disease and future deterioration of metabolic health: A cohort study. Obesity (Silver Spring) 27(8), 1360\u20131366 (2019).","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"18988_CR27","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1210\/jc.2012-4253","volume":"98","author":"F Soriguer","year":"2013","unstructured":"Soriguer, F. et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. J. Clin. Endocrinol. Metab. 98(6), 2318\u20132325 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"15","key":"18988_CR28","doi-asserted-by":"publisher","first-page":"e3384","DOI":"10.1097\/MD.0000000000003384","volume":"95","author":"NH Kim","year":"2016","unstructured":"Kim, N. H. et al. Risk of the development of diabetes and cardiovascular disease in metabolically healthy obese people: The Korean Genome and epidemiology study. Medicine (Baltimore) 95(15), e3384 (2016).","journal-title":"Medicine (Baltimore)"},{"issue":"40","key":"18988_CR29","doi-asserted-by":"publisher","first-page":"e1705","DOI":"10.1097\/MD.0000000000001705","volume":"94","author":"SH Lee","year":"2015","unstructured":"Lee, S. H. et al. Changes in metabolic health status over time and risk of developing type 2 diabetes: A prospective cohort study. Medicine (Baltimore) 94(40), e1705 (2015).","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"18988_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ijo.2014.113","volume":"39","author":"I Achilike","year":"2015","unstructured":"Achilike, I. et al. Predicting the development of the metabolically healthy obese phenotype. Int. J. Obes. (Lond) 39(2), 228\u2013234 (2015).","journal-title":"Int. J. Obes. (Lond)"},{"issue":"5","key":"18988_CR31","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1530\/EJE-15-0449","volume":"173","author":"M Hamer","year":"2015","unstructured":"Hamer, M. et al. Stability of metabolically healthy obesity over 8 years: The English longitudinal study of ageing. Eur. J. Endocrinol. 173(5), 703\u2013708 (2015).","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"18988_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jacc.2014.09.077","volume":"65","author":"JA Bell","year":"2015","unstructured":"Bell, J. A. et al. The natural course of healthy obesity over 20 years. J. Am. Coll. Cardiol. 65(1), 101\u2013102 (2015).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"18988_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ijo.2016.179","volume":"41","author":"GC Kabat","year":"2017","unstructured":"Kabat, G. C. et al. Metabolic phenotypes of obesity: Frequency, correlates and change over time in a cohort of postmenopausal women. Int. J. Obes. (Lond) 41(1), 170\u2013177 (2017).","journal-title":"Int. J. Obes. (Lond)"},{"issue":"9","key":"18988_CR34","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","volume":"6","author":"N Eckel","year":"2018","unstructured":"Eckel, N. et al. Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90257 women (the Nurses\u2019 Health Study): 30 year follow-up from a prospective cohort study. Lancet Diabetes Endocrinol. 6(9), 714\u2013724 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"10","key":"18988_CR35","doi-asserted-by":"publisher","first-page":"e1003351","DOI":"10.1371\/journal.pmed.1003351","volume":"17","author":"M Gao","year":"2020","unstructured":"Gao, M. et al. Metabolically healthy obesity, transition to unhealthy metabolic status, and vascular disease in Chinese adults: A cohort study. PLoS Med. 17(10), e1003351 (2020).","journal-title":"PLoS Med."},{"issue":"7","key":"18988_CR36","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1042\/CS20140553","volume":"128","author":"R Taylor","year":"2015","unstructured":"Taylor, R. & Holman, R. R. Normal weight individuals who develop type 2 diabetes: The personal fat threshold. Clin. Sci. (Lond) 128(7), 405\u2013410 (2015).","journal-title":"Clin. Sci. (Lond)"},{"issue":"1","key":"18988_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s12020-017-1313-6","volume":"57","author":"Y Hashimoto","year":"2017","unstructured":"Hashimoto, Y. et al. Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. Endocrine 57(1), 89\u201397 (2017).","journal-title":"Endocrine"},{"issue":"10","key":"18988_CR38","doi-asserted-by":"publisher","first-page":"e34288","DOI":"10.1136\/bmjopen-2019-034288","volume":"10","author":"L Zhou","year":"2020","unstructured":"Zhou, L. et al. Income-related inequities of adult obesity and central obesity in China: Evidence from the China Health and Nutrition Survey 1997\u20132011. BMJ Open 10(10), e34288 (2020).","journal-title":"BMJ Open"},{"issue":"1","key":"18988_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/14756366.2021.2020773","volume":"37","author":"A Nocentini","year":"2022","unstructured":"Nocentini, A. et al. Pharmaceutical strategies for preventing toxicity and promoting antioxidant and anti-inflammatory actions of bilirubin. J. Enzyme Inhib. Med. Chem. 37(1), 487\u2013501 (2022).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"13","key":"18988_CR40","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1073\/pnas.0813132106","volume":"106","author":"TW Sedlak","year":"2009","unstructured":"Sedlak, T. W. et al. Bilirubin and glutathione have complementary antioxidant and cytoprotective roles. Proc. Natl. Acad. Sci. U S A 106(13), 5171\u20135176 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"18988_CR41","doi-asserted-by":"publisher","first-page":"29240","DOI":"10.1038\/srep29240","volume":"6","author":"L Ziberna","year":"2016","unstructured":"Ziberna, L. et al. Bilirubin is an endogenous antioxidant in human vascular endothelial cells. Sci. Rep. 6, 29240 (2016).","journal-title":"Sci. Rep."},{"issue":"2","key":"18988_CR42","first-page":"e914","volume":"5","author":"JJ DiNicolantonio","year":"2018","unstructured":"DiNicolantonio, J. J., McCarty, M. F. & O\u2019Keefe, J. H. Antioxidant bilirubin works in multiple ways to reduce risk for obesity and its health complications. Open Heart 5(2), e914 (2018).","journal-title":"Open Heart"},{"issue":"11","key":"18988_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11906-019-0994-z","volume":"21","author":"TJ Hinds","year":"2019","unstructured":"Hinds, T. J. & Stec, D. E. Bilirubin safeguards cardiorenal and metabolic diseases: A protective role in health. Curr. Hypertens. Rep. 21(11), 87 (2019).","journal-title":"Curr. Hypertens. Rep."},{"issue":"1","key":"18988_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam, M. et al. A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J. Hepatol. 73(1), 202\u2013209 (2020).","journal-title":"J. Hepatol."},{"issue":"4","key":"18988_CR45","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ajg.2009.67","volume":"104","author":"LA Adams","year":"2009","unstructured":"Adams, L. A. et al. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: An eleven-year follow-up study. Am. J. Gastroenterol. 104(4), 861\u2013867 (2009).","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"18988_CR46","doi-asserted-by":"publisher","first-page":"e96651","DOI":"10.1371\/journal.pone.0096651","volume":"9","author":"T Zhang","year":"2014","unstructured":"Zhang, T. et al. Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: A prospective cohort study. PLoS ONE 9(5), e96651 (2014).","journal-title":"PLoS ONE"},{"issue":"48","key":"18988_CR47","doi-asserted-by":"publisher","first-page":"18273","DOI":"10.1073\/pnas.0608537103","volume":"103","author":"KF Petersen","year":"2006","unstructured":"Petersen, K. F. et al. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc. Natl. Acad. Sci. U S A 103(48), 18273\u201318277 (2006).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"9","key":"18988_CR48","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1172\/JCI31021","volume":"117","author":"JY Kim","year":"2007","unstructured":"Kim, J. Y. et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J. Clin. Invest. 117(9), 2621\u20132637 (2007).","journal-title":"J. Clin. Invest."},{"issue":"11","key":"18988_CR49","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/eci.12519","volume":"45","author":"SM Grundy","year":"2015","unstructured":"Grundy, S. M. Adipose tissue and metabolic syndrome: Too much, too little or neither. Eur. J. Clin. Invest. 45(11), 1209\u20131217 (2015).","journal-title":"Eur. J. Clin. Invest."},{"issue":"2","key":"18988_CR50","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s11901-016-0302-1","volume":"15","author":"J Wattacheril","year":"2016","unstructured":"Wattacheril, J. & Sanyal, A. J. Lean NAFLD: An underrecognized outlier. Curr. Hepatol. Rep. 15(2), 134\u2013139 (2016).","journal-title":"Curr. Hepatol. Rep."},{"issue":"4","key":"18988_CR51","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.cgh.2016.08.028","volume":"15","author":"D Kim","year":"2017","unstructured":"Kim, D. & Kim, W. R. Nonobese fatty liver disease. Clin. Gastroenterol. Hepatol. 15(4), 474\u2013485 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"18988_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross, R. et al. Waist circumference as a vital sign in clinical practice: A consensus statement from the IAS and ICCR working group on visceral obesity. Nat. Rev. Endocrinol. 16(3), 177\u2013189 (2020).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"8","key":"18988_CR53","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: A systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5(8), 739\u2013752 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10","key":"18988_CR54","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.dld.2019.02.019","volume":"51","author":"C Shao","year":"2019","unstructured":"Shao, C. et al. Different predictors of steatosis and fibrosis severity among lean, overweight and obese patients with nonalcoholic fatty liver disease. Dig. Liver Dis. 51(10), 1392\u20131399 (2019).","journal-title":"Dig. Liver Dis."},{"issue":"18","key":"18988_CR55","doi-asserted-by":"publisher","first-page":"e6712","DOI":"10.1097\/MD.0000000000006712","volume":"96","author":"H Yoshitaka","year":"2017","unstructured":"Yoshitaka, H. et al. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study. Medicine (Baltimore) 96(18), e6712 (2017).","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"18988_CR56","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.jceh.2021.01.004","volume":"11","author":"NS Choudhary","year":"2021","unstructured":"Choudhary, N. S. et al. Nonalcoholic fatty liver in lean individuals: Clinicobiochemical correlates of histopathology in 157 liver biopsies from healthy liver donors. J. Clin. Exp. Hepatol. 11(5), 544\u2013549 (2021).","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"19","key":"18988_CR57","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","volume":"164","author":"HJ Kim","year":"2004","unstructured":"Kim, H. J. et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch. Intern. Med. 164(19), 2169\u20132175 (2004).","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"18988_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2337\/cd18-0026","volume":"37","author":"P Golabi","year":"2019","unstructured":"Golabi, P. et al. Patients with lean nonalcoholic fatty liver disease are metabolically abnormal and have a higher risk for mortality. Clin. Diabetes 37(1), 65\u201372 (2019).","journal-title":"Clin. Diabetes"},{"issue":"3","key":"18988_CR59","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/MCG.0b013e31826be328","volume":"47","author":"A Margariti","year":"2013","unstructured":"Margariti, A. et al. The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 47(3), 280\u2013286 (2013).","journal-title":"J. Clin. Gastroenterol."},{"issue":"2","key":"18988_CR60","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/gutjnl-2020-322564","volume":"71","author":"R Younes","year":"2022","unstructured":"Younes, R. et al. Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: Time for reappraisal of BMI-driven approach? Gut 71(2), 382\u2013390 (2022).","journal-title":"Gut"},{"issue":"1","key":"18988_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/hep4.1124","volume":"2","author":"H Hagstr\u00f6m","year":"2018","unstructured":"Hagstr\u00f6m, H. et al. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long-term follow-up study. Hepatol. Commun. 2(1), 48\u201357 (2018).","journal-title":"Hepatol. Commun."},{"issue":"2","key":"18988_CR62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/apt.14112","volume":"46","author":"S Sookoian","year":"2017","unstructured":"Sookoian, S. & Pirola, C. J. Systematic review with meta-analysis: Risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol. Ther. 46(2), 85\u201395 (2017).","journal-title":"Aliment Pharmacol. Ther."},{"issue":"4","key":"18988_CR63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/hep.30702","volume":"70","author":"F Zhou","year":"2019","unstructured":"Zhou, F. et al. Unexpected rapid increase in the burden of NAFLD in China From 2008 to 2018: A systematic review and meta-analysis. Hepatology 70(4), 1119\u20131133 (2019).","journal-title":"Hepatology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18988-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18988-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18988-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T10:18:24Z","timestamp":1661941104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-18988-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["18988"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-18988-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]},"assertion":[{"value":"29 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14786"}}